lercanidipine has been researched along with Inflammation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gül, S; Hüseynov, İ; Milletsever, A; Selçuk, E; Selli, J; Tepebaşı, MY | 1 |
| Agabiti-Rosei, C; Agabiti-Rosei, E; Airò, P; Caimi, L; De Ciuceis, C; Ricotta, D; Rizzoni, D; Rossini, C; Ruggeri, G; Scarsi, M; Tincani, A | 1 |
| Farah, R; Shurtz-Swirski, R | 1 |
| Chen, IJ; Hsu, JH; Liang, JC; Liou, SF; Yeh, JL | 1 |
| Farah, R; Klempef, R; Kristal, B; Sela, S; Shapiro, G; Shurtz-Swirski, R; Snitkovski, T | 1 |
1 trial(s) available for lercanidipine and Inflammation
| Article | Year |
|---|---|
The combined effect of calcium channel blocker Lercanidipine and antioxidants on low-grade systemic inflammation parameters in essential hypertension patients.
Topics: Adult; Antioxidants; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Inflammation; Male; Middle Aged | 2008 |
4 other study(ies) available for lercanidipine and Inflammation
| Article | Year |
|---|---|
Lercanidipine alleviates doxorubicin-induced lung injury by regulating PERK/CHOP and Bax/Bcl 2/Cyt c pathways.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Doxorubicin; Inflammation; Lung Injury; Rats | 2023 |
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension.
Topics: Antihypertensive Agents; Dihydropyridines; Endothelial Progenitor Cells; Essential Hypertension; Female; Humans; Hypertension; Inflammation; Male; Middle Aged; Risk Factors | 2016 |
Lercanidipine and labedipinedilol--A attenuate lipopolysaccharide/interferon-γ-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities.
Topics: Animals; Anisoles; Anti-Inflammatory Agents; Dihydropyridines; HMGB1 Protein; Inflammation; Interferon-gamma; Lipopolysaccharides; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Rats; Tissue Inhibitor of Metalloproteinase-1 | 2013 |
[The effect of calcium channel blocker lercanidipine on lowgrade inflammation parameters in essential hypertension patients].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Inflammation; Middle Aged; Neutrophils | 2006 |